Table 2

Demographic and zoster characteristics

Demographic/zoster characteristicTreatment group
Famciclovir 500 mg three times daily (n = 251)Aciclovir 800 mg 5 × daily (n = 203)
Male, No (%)120 (48%)93 (46%)
Mean age, years (range) 59 (19–93)58 (20–93)
Race, No (%)
 White235 (94%)195 (96%)
 Black10 (4%)6 (3%)
 Other6 (2%)2 (1%)
Duration of zoster rash at start of treatment
 0–48 Hours135 (54%)117 (58%)
 49–72 Hours116 (46%)86 (42%)
Number of lesions within primary affected dermatome
 1–24172 (69%)140 (69%)
 25–5062 (25%)46 (23%)
  >5017 (7%)17 (8%)